IP Library Patent Application 12497666
Patent Application
App. No. 12/497,666

Composition and Method for Analysis of Target Analytes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/497,666
Abstract

A method of detecting analytes includes providing a mixture containing analytes to be analyzed and microparticles coated with competitive inhibitors of the analytes. First antibodies are reacted with the analytes and the competitive inhibitors under competitive binding conditions. The first antibodies bound to the competitive inhibitors are measured using flow cytometry.

Claims (15)

1 . A method of detecting analytes, comprising the steps of:

providing a mixture containing analytes to be analyzed and microparticles coated with competitive inhibitors of the analytes;

reacting first antibodies with the analytes and the competitive inhibitors under competitive binding conditions; and

measuring the first antibodies bound to the competitive inhibitors using flow cytometry.

2 . The method of claim 1 wherein said first antibodies are labeled with a fluorescent moiety.

3 . The method of claim 2 , wherein said first antibodies are labeled by binding to second antibodies comprising a fluorescent moiety.

4 . The method of claim 1 wherein said measuring step comprises using a microcapillary flow cytometer.

5 . The method of claim 1 wherein the amount of the first antibodies is sufficient to bind about 10 to 100 percent of the competitive inhibitors on the microparticles.

6 . The method of claim 1 wherein the amount of the first antibodies is sufficient to bind about 10 to 75 percent of the competitive inhibitors on the microparticles.

7 . The method of claim 1 wherein said competitive inhibitors have a structure same or substantially same as that of said analytes.

8 . The method of claim 1 wherein said analytes are cell-associated.

9 . The method of claim 1 wherein said analytes are not cell-associated.

10 . The method of claim 1 wherein said analytes comprise hormones, enzymes, chemokines, cytokines, insulin, and signal transduction molecules.

11 . The method of claim 1 wherein said analytes are insulin.

12 . The method of claim 1 wherein said first antibodies comprise monoclonal antibodies.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2012
From: MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 027620/0891 →
MERGER Recorded Mar 9, 2010
From: GUAVA TECHNOLOGIES, INC.
To: MILLIPORE CORPORATION
Reel/Frame 024045/0455 →